BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 313056)

  • 1. Biochemical basis for the enhanced toxicity of deoxyribonucleosides toward malignant human T cell lines.
    Carson DA; Kaye J; Matsumoto S; Seegmiller JE; Thompson L
    Proc Natl Acad Sci U S A; 1979 May; 76(5):2430-3. PubMed ID: 313056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purinogenic immunodeficiency diseases: selective toxicity of deoxyribonucleosides for T cells.
    Mitchell BS; Mejias E; Daddona PE; Kelley WN
    Proc Natl Acad Sci U S A; 1978 Oct; 75(10):5011-4. PubMed ID: 311004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical basis for differential deoxyadenosine toxicity to T and B lymphoblasts: role for 5'-nucleotidase.
    Wortmann RL; Mitchell BS; Edwards NL; Fox IH
    Proc Natl Acad Sci U S A; 1979 May; 76(5):2434-7. PubMed ID: 221924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diverse deoxyribonucleotide profiles in cultured human cells with differential sensitivity to thymidine.
    Leyva A; Appel H; Pinedo HM
    Cancer Biochem Biophys; 1984 Sep; 7(3):231-7. PubMed ID: 6333268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purine and pyrimidine metabolism in human T lymphocytes. Regulation of deoxyribonucleotide metabolism.
    Cohen A; Barankiewicz J; Lederman HM; Gelfand EW
    J Biol Chem; 1983 Oct; 258(20):12334-40. PubMed ID: 6605343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purine deoxyribonucleosides counteract effects of hydroxyurea on deoxyribonucleoside triphosphate pools and DNA synthesis.
    Lagergren J; Reichard P
    Biochem Pharmacol; 1987 Sep; 36(18):2985-91. PubMed ID: 3498491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the mechanism of deoxyribonucleoside toxicity in human T-lymphoblastoid cells. Reversal of growth inhibition by addition of cytidine.
    Dahbo Y; Eriksson S
    Eur J Biochem; 1985 Aug; 150(3):429-34. PubMed ID: 3874778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential metabolism of deoxyribonucleosides by leukaemic T cells of immature and mature phenotype.
    Sidi Y; Edwards NL; Winkler C; Bunn P; Mitchell BS
    Br J Haematol; 1985 Sep; 61(1):125-34. PubMed ID: 2996581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B cells as well as T cells form deoxynucleotides from either deoxyadenosine or deoxyguanosine.
    Goday A; Simmonds HA; Morris GS; Fairbanks LD
    Clin Exp Immunol; 1984 Apr; 56(1):39-48. PubMed ID: 6424986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of deoxycoformycin and deoxyadenosine on deoxyribonucleotide concentrations in leukaemic cells.
    Sylwestrowicz T; Piga A; Murphy P; Ganeshaguru K; Russell NH; Prentice HG; Hoffbrand AV
    Br J Haematol; 1982 Aug; 51(4):623-30. PubMed ID: 6980665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible role for 5'-nucleotidase in deoxyadenosine selective toxicity to cultured human lymphoblasts.
    Wortmann RL; Mitchell BS; Edwards NL; Fox IH
    Adv Exp Med Biol; 1979; 122B():243-59. PubMed ID: 232631
    [No Abstract]   [Full Text] [Related]  

  • 12. Purine metabolizing enzymes as predictors of lymphoblast sensitivity to deoxyadenosine.
    Mitchell BS; Edwards NL
    J Lab Clin Med; 1984 Sep; 104(3):414-24. PubMed ID: 6147383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitivity of leukemic human null lymphocytes to deoxynucleosides.
    Fox RM; Tripp EH; Piddington SK; Tattersall MH
    Cancer Res; 1980 Sep; 40(9):3383-6. PubMed ID: 6253063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uniqueness of deoxyribonucleotide metabolism in human malignant T cell lines.
    Carson DA; Kaye J; Matsumoto S; Seegmiller JE; Thompson L
    Adv Exp Med Biol; 1979; 122B():381-8. PubMed ID: 317570
    [No Abstract]   [Full Text] [Related]  

  • 15. Mechanism of deoxyadenosine-induced catabolism of adenine ribonucleotides in adenosine deaminase-inhibited human T lymphoblastoid cells.
    Bagnara AS; Hershfield MS
    Proc Natl Acad Sci U S A; 1982 Apr; 79(8):2673-7. PubMed ID: 6283540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The rate of catabolism of dATP to deoxyadenosine during the growth of different cell lines in vitro.
    Marcussen M; Klenow H
    FEBS Lett; 1992 Mar; 299(2):143-5. PubMed ID: 1544486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in deoxyribonucleotide metabolism in cultured cells with ribonucleotide reductase activities refractory to feedback inhibition by 2'-deoxyadenosine triphosphate.
    Ullman B; Clift SM; Gudas LJ; Levinson BB; Wormsted MA; Martin DW
    J Biol Chem; 1980 Sep; 255(17):8308-14. PubMed ID: 6997294
    [No Abstract]   [Full Text] [Related]  

  • 18. Protective effect of deoxyribonucleosides on UV-irradiated human peripheral blood T-lymphocytes: possibilities for the selective killing of either cycling or non-cycling cells.
    Green MH; Waugh AP; Lowe JE; Harcourt SA; Clingen PH; Cole J; Arlett CF
    Mutat Res; 1996 Feb; 350(1):239-46. PubMed ID: 8657186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accumulation of deoxyribonucleotides as a possible mediator of immunosuppression in hereditary deficiency of adenosine deaminase.
    Bluestein HG; Willis RC; Thompson LF; Matsumoto S; Seegmiller JE
    Trans Assoc Am Physicians; 1978; 91():394-402. PubMed ID: 314193
    [No Abstract]   [Full Text] [Related]  

  • 20. Determinants of deoxyadenosine toxicity in hybrids between human T- and B- lymphoblasts as a model for the development of drug resistance in T-cell acute lymphoblastic leukemia.
    Kurtzberg J; Hershfield MS
    Cancer Res; 1985 Apr; 45(4):1579-86. PubMed ID: 3872167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.